BICTF
Biocure Technology Inc.
Set alert
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.07
- Prev close
- 0.01
- Mkt cap
- 202.07K
- Vol
- 1.00K
- Avg vol
- 0
- EPS
- -0.02
- P/E
- 0.00
More statistics
- Low
- 0.07
- High
- 0.07
News
5 months ago thenewswire.com
Biocure Technology Inc. Announces Adoption of Semi-Annual Reporting
Vancouver, B.C. – TheNewswire - May 8, 2026 ‐ Biocure Technology Inc. (CSE: CURE) (OTCQB: BICTF) (the “ Company” or “Biocure”) announces the adoption of semi-annual financial reporting. This news…
2 years ago newsfilecorp.com
CSE Bulletin: Consolidation - Biocure Technology Inc. (CURE.X)
Toronto, Ontario--(Newsfile Corp. - le 23 octobre/October 2024) - Biocure Technology Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1)…
3 years ago globenewswire.com
Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology
TÜBINGEN, Germany and MUNICH, Germany, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Atriva Therapeutics GmbH (“Atriva”) is pleased to disclose the signing of an exclusive letter agreement, dated September 14,…
3 years ago newsfilecorp.com
Biocure Technology Inc. Enters into Exclusive Letter Agreement to Acquire Atriva Therapeutics GmbH in Reverse Takeover Transaction
Vancouver, British Columbia--(Newsfile Corp. - September 18, 2023) - Biocure Technology Inc. (CSE: CURE) ("CURE" or the "Company") announces that it has entered into an exclusive letter agreement…
5 years ago newsfilecorp.com
BioCure Technology Inc. Announces New President, Appointment of Capital Markets Advisor and Grant of Stock Options
Vancouver, British Columbia--(Newsfile Corp. - July 22, 2021) - BioCure Technology Inc., (CSE: CURE) (OTCQB: BICTF) (CURE or the Company) is pleased to announce that Björn Cochlovius, Ph.D,…
5 years ago newsfilecorp.com
BioCure Technology Inc. Announces Closing of Financing
Vancouver, British Columbia--(Newsfile Corp. - July 14, 2021) - BioCure Technology Inc. (CSE: CURE) ("BioCure" or the "Company") announces that it has successfully closed a non-brokered private…
5 years ago newsfilecorp.com
BiocurePharm, Korea (BPK) Signs MOU With Symbasis GmbH to Develop CAR-T Therapy for Chronic Lymphocyte Leukemia (CLL)
Vancouver, British Columbia--(Newsfile Corp. - January 4, 2021) - Biocure Technology Corp. (CSE: CURE) (OTCQB: BICTF) (CURE or the Company) BiocurePharm, Korea (BPK), a subsidiary of Biocure…